MedPath

AHS Cancer Control Alberta

๐Ÿ‡จ๐Ÿ‡ฆCanada
Ownership
Private
Employees
-
Market Cap
-
Website

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

Not Applicable
Completed
Conditions
Diffuse Large B Cell Lymphoma
Interventions
Drug: R-CHOP
Procedure: Autologous Blood Stem Transplantation
First Posted Date
2007-09-17
Last Posted Date
2019-01-22
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
69
Registration Number
NCT00530179
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Ottawa General Hospital, Ottawa, Ontario, Canada

๐Ÿ‡จ๐Ÿ‡ฆ

Tom Baker Cancer Centre, Calgary, Alberta, Canada

๐Ÿ‡จ๐Ÿ‡ฆ

Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Completed
Conditions
Squamous Cell Cancer
Interventions
Other: PET-CT
First Posted Date
2007-09-17
Last Posted Date
2019-10-21
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
20
Registration Number
NCT00530283
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Blood Test to Measure DNA Damage in Blood

Terminated
Conditions
Prostate Cancer
First Posted Date
2007-08-31
Last Posted Date
2016-02-26
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
40
Registration Number
NCT00523471
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial

Not Applicable
Completed
Conditions
Breast Neoplasms
Interventions
Behavioral: Aerobic exercise intervention
First Posted Date
2007-08-29
Last Posted Date
2015-01-15
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
320
Registration Number
NCT00522262
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Alberta Cancer Board, Calgary, Alberta, Canada

๐Ÿ‡จ๐Ÿ‡ฆ

University of Alberta, Edmonton, Alberta, Canada

A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia

Not Applicable
Conditions
Head and Neck Cancer
First Posted Date
2007-07-06
Last Posted Date
2016-03-16
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
46
Registration Number
NCT00497406
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

Aerobic Capacity and Body Composition in Colon Cancer Patients

Completed
Conditions
Colonic Neoplasms
First Posted Date
2007-05-08
Last Posted Date
2016-02-26
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
40
Registration Number
NCT00470782
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Phase 1
Completed
Conditions
Lung Neoplasm
Small Cell Carcinoma
First Posted Date
2007-05-04
Last Posted Date
2016-02-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
24
Registration Number
NCT00469222
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

Tomotherapy Treatment for Mesothelioma

Phase 2
Completed
Conditions
Mesothelioma
First Posted Date
2007-05-04
Last Posted Date
2016-04-06
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
18
Registration Number
NCT00469196
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

Cone Beam CT Scanning in Lung and Bladder Cancer.

Completed
Conditions
Bladder Carcinoma
Lung Neoplasm
Small Cell Carcinoma
First Posted Date
2007-05-04
Last Posted Date
2016-02-24
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
22
Registration Number
NCT00469066
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

The Feasibility of Physical Activity in Advanced Cancer Patients

Completed
Conditions
Advanced Cancer
First Posted Date
2007-02-22
Last Posted Date
2016-02-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
30
Registration Number
NCT00438620
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Cross Cancer Institute, Edmonton, Alberta, Canada

ยฉ Copyright 2025. All Rights Reserved by MedPath